Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
| DRUGNAME | PT | EventCount |
|---|---|---|
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Incarcerated hernia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Incarcerated inguinal hernia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Inguinal hernia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Insomnia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Lumbar radiculopathy | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Mental status changes | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Mouth ulceration | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Muscular weakness | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Musculoskeletal pain | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Neuralgia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Nipple pain | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Oedema peripheral | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Oxygen saturation decreased | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Pain in extremity | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Paraesthesia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Polyneuropathy | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Postoperative wound infection | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Proctalgia | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Protein urine present | 1 |
| RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Pseudomonas infection | 1 |
Total Records: 1,104 Number of Pages: 56